Company & Sponsor Intelligence

Wake Forest University Health Sciences

Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.

Request enterprise analysis →

Indexed trials9

Recruiting1

Completed4

Countries1

Therapeutic footprint

alsalzheimersepilepsyneuromuscularother_neurologyparkinsonsstroke

Indexed studies

NCT05353452Collaborative Care in Posttraumatic Epilepsy
epilepsy · United StatesNA

NCT03682874Identifying Novel Aging Targets for Treatment of Delirium
alzheimers · United StatesTERMINATED

NCT01950910Establishment of a Tissue Bank (Blood, CSF) for the Understanding of Motor Neuron Disease (MND)
als · United StatesTERMINATED

NCT04493697Using Neuromodulation to Improve Parkinson's Disease
parkinsons · United StatesNA

NCT05173506Child Health Improvement Through Computer Automation - Child Neurology (CHICA-CN) Evaluation
other_neurology · United StatesCOMPLETED

NCT04164043Efficacy of a Recreation Therapy Wellness Recovery Program for Individuals With Parkinson's Disease
parkinsons · United StatesNA

NCT05559749Collaborative Care for Anxiety and Depression in Epilepsy
epilepsy · United StatesNA

NCT04963075Multisensory Rehabilitation of Hemianopia
stroke · United StatesNA

NCT01950897Muscle Tissue Bank for Muscular Dystrophy
neuromuscular · United StatesCOMPLETED

Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00

Enterprise intelligence

Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.

Request comparative intelligence →